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Abstract 
Best available research evidence is essential but not the only type of 
evidence needed in public health decision making. Decisions are also 
influenced and must take into account factors other than research evidence.  
This approach in public health is called evidence-informed public health 
(EIPH). A fundamental concept of EIPH is to take into account realities of a 
specific real-world environment when translating research evidence into 
policy and practice. Therefore approaches to co-creation of best available 
evidence for decision making - evidence that is informed by best available 
research evidence but that also incorporates other types of information to 
address decision makers’ needs - are necessary for knowledge translation in 
public health. This thesis includes published works which report findings on 
1) the use of research and other types of evidence and barriers and 
facilitators of its use and 2) KT approaches facilitating co-creation of best 
available evidence in public health policy making and practice. The eight 
publications included in this thesis studied factors associated with evidence 
use and present examples of co-creating evidence. The published works on 
evidence use (Publications 1 and 2) were undertaken using qualitative 
methods, specifically, content analysis of policy documents and interviews 
with decision makers within physical activity policy-making. Examples of co-
creating evidence to address barriers identified in Publication 2 (such as 
relevance of research, lack of resources, lack of applicability of research etc.) 
used the Delphi technique, Population Impact Measure and Coverage with 
Evidence Development methodologies. They were applied to inform public 
health policy and practice in areas which include SARS and SARS-like 
diseases (Publications 3 and 4), rare diseases (Publication 5), cardiovascular 
diseases, strokes, cancers (Publication 6) and Dupuytren’s disease 
(Publication 7 and 8). It is essential that approaches supporting the use of 
research and other types of evidence in public health continue to be 
developed and documented, and this thesis represents such an endeavour. 
Usefulness and effectiveness of different KT approaches facilitating evidence 
use and reduce its barriers must also be continuously evaluated as they are 
adopted or modified to deal with different issues in different settings. 
Effective interventions along with strategies facilitating their delivery and 
implementation can then be utilised by public health professionals and policy 
makers who wish to promote EIPH. 
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Section 1: Background 
Section 1.1: Evidence and Public Health 
Research continually produces new findings that can contribute to effective 
and efficient healthcare (Eccles and Mittman 2006). However, such research 
cannot change health outcomes unless healthcare decision makers adopt 
findings into healthcare services. Public health, defined as ‘the science and 
art of promoting and protecting health and well-being, preventing ill-health 
and prolonging life through the organised efforts of society’ (WHO 1998), 
influences health outcomes at population level through public health policy 
and practice.  
In the context of public health policy and practice, two types of evidence are 
used - explicit (or research) evidence and implicit (or tacit) evidence. Explicit 
evidence comes from “articulated theories and empirical observations” made 
using systematic processes and scientific methods (Bhattacharyya et al 
2009). Implicit (or tacit) evidence, on the contrary, comes from the 
“judgement of individuals with extensive experience in an area” 
(Bhattacharyya et al 2009) and as such is built and shaped by the 
experiences and values of individuals within a given setting or context. This 
type of evidence is difficult to formalise and communicate with other people, 
but is seen as closely “linked to action in context” (Greenhalgh and Wieringa, 
2011). Implicit evidence is often called ‘other types’ of evidence (as oppose 
to research evidence). In this thesis, the term ‘evidence’ is generally used in 
its broad sense encompassing both research evidence and other types of 
evidence unless otherwise specified. 
Systematically incorporating research evidence in public health policies and 
practice supports the provision of high-quality, effective, and efficient health 
services and improved health outcomes. This further ensures a more 
responsible use of the financial and human resource investments that are 
made in public health (Grimshaw et al 2012, Straus et al 2009).  Therefore, 
in recent years, the use of research evidence to underpin public health policy 
and practice has been strongly promoted (Orton et al 2011). This has 
occurred as a natural conceptual development from the well-established 
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evidence-based medicine movement (Harpham and Taun 2006, Kirkwood et 
al 2004). Increased focus on Evidence-Based Public Health (EBPH), defined 
as the development, implementation, and evaluation of effective policies and 
programs in public health through application of principles of scientific 
reasoning i.e use of research evidence (Brownson et al 2003), has numerous 
direct and indirect benefits (Brownson et al 2009). However, decisions are 
also influenced and must take into account factors other than research 
evidence. Best available research evidence is essential but not the only type 
of evidence that needs be taken into account in public health decision 
making (Satterfield et al 2009 and Oxman et al 2009). Given the benefits of 
using other types of evidence in public health decisions, public health 
professionals and decision makers are increasingly expected to engage in 
Evidence-Informed Decision Making (EIDM). 
Section 1.2: Evidence-informed Decision Making and Public 
Health
EIDM involves integrating the best available research evidence along with 
other types of evidence which consists of contextual factors including 
community preferences, local issues (e.g., health, social), political 
preferences, and public health resources (Brownson et al 2009 and Nu
tley et al 2003). EIDM considers research evidence as one form of a range of 
sources of evidence that are used to inform policy and practice (Bowen et al 
2005). In EIDM, best available evidence includes two core components - 
best available explicit evidence and best available implicit evidence. Decision 
makers must draw on explicit and implicit evidence and their expertise to 
incorporate all the relevant factors into the final decision, conclusion or 
recommendation. The weight and influence that each have on the decision-
making process will depend upon the specific circumstances, as well as the 
skills and values held by the individuals and groups involved in the process. 
In an ideal scenario which involves developing public health policy or 
practice, explicit evidence forms the primary source of information in the 
decision making process and is supplemented by implicit evidence in order 
to make it relevant and applicable to the local context and need.  This 
approach in public health is called evidence-informed public health (EIPH) 
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and its benefits include adoption of the most effective and cost-efficient 
interventions (Lavis et al 2009), minimized harm to people and communities 
(Macintyre and Petticrew 2000, Chalmers 2003, Chalmers 2005) and better 
health outcomes for individuals and communities (Task Force on Health 
Systems Research 2004).  
It is recognised that strengthening the use of evidence, and the ability of 
policymakers (and public health practitioners) to make appropriate 
judgements about its quality and relevance, is a critical challenge that holds 
the promise of helping to achieve significant health gains and better use of 
resources (Oxman et al 2009). Therefore, in recent years, concepts such as 
‘Knowledge Translation (KT)’ and ‘Implementation Science (IS)’ have been 
developed and are also increasingly being used in public health. 
Furthermore, frameworks such as the “knowledge-to-action” (which includes 
the concepts of KT and implementation Science) have been conceptualized 
by many authors, notably by Graham and colleagues (Canadian Institutes of 
Health Research 2010, Graham et al 2006). They describe the dynamic 
process from knowledge creation to application. Such frameworks are 
recommended as a way of preparing for the multiple, dynamic and interactive 
factors that influence the uptake of evidence in developing public health 
policy and practice.  
Section 1.3: Knowledge Translation and Implementation Science 
The term KT is used in public health research, policy and practice settings to 
describe the processes needed to facilitate EIDM (Armstrong 2006). KT is 
defined as approaches to increasing the use of evidence within policy and 
practice decision-making contexts and is critically important given the many 
gaps that exist between what we know and what is actually done (evidence-
to-policy and evidence-to-practice gaps). It includes approaches to co-
creating evidence. Designing interventions to foster the use of evidence 
requires an understanding of the processes through which public health 
professionals and decision makers assess and use evidence, including 
barriers and facilitators related to evidence uptake.  KT does not, however, 
cover how to implement knowledge to achieve its intended outcomes (Khalil 
2016). Implementation science addresses this gap of how to adopt a new 
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intervention (Khalil 2016) to achieve its intended outcomes.  It is defined as 
the scientific study of methods to promote the systematic uptake of research 
findings and other evidence-based practices into routine practice, and, 
hence, to improve the quality and effectiveness of health services (Eccles 
and Mittman 2006).  
Kiefer et al (2005) highlight that KT approaches have not provided the 
positive changes in EIPH that had been anticipated (Kiefer et al 2005). One 
possible reason for failure could be the narrow definition of evidence as 
research evidence in the earlier KT literature (Kothari et al 2011), where KT 
in public health has typically adopted a narrow scope, with formal, explicit 
scientific research represented as the evidence being translated for use in 
practice and/or policy decision-making (Kothari et al 2012). Therefore there 
is a need to explore KT approaches facilitating co-creation of evidence in its 
broader sense to foster EIPH. 
Section 1.4: Co-creation of Evidence in Public Health 
A fundamental concept of EIPH is to take into account realities of a specific 
real-world environment when translating evidence into policy and practice. 
Early literature tended to overemphasize internal validity (i.e. explicit 
evidence) (e.g., risk and burden of diseases for narrowly-defined populations 
and precise estimates from well-controlled efficacy trials) while giving sparse 
attention to external validity (i.e. implicit evidence) (e.g., the translation of 
science to the various circumstances of practice) (Glasgow et al 2006, Green 
et al 2006). However, integrating both explicit and implicit evidence is 
essential (Kamper-Jõrgensen, 2000) as explicit evidence is rarely perfect. As 
noted by Muir Gray (1997), “the absence of excellent evidence does not 
make decision making impossible; what is required is the best evidence 
available not the best evidence possible”. Therefore approaches to co-create 
best available evidence for decision making - evidence that is informed by 
best available research evidence but that also incorporates other types of 
evidence to address decision makers’ needs - are necessary for EIPH. Co-
creation of evidence is therefore defined in this thesis as any approach to 
integrate best available research evidence together with best available other 
types of evidence such as patient’s expectations, clinicians’ perspectives, 
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local data, resources etc. to inform EIPH/EIDM. This is consistent with the 
definition of co-creation in the published literature (Greenhalgh et al 2016).   
Section 1.5: Conceptual Framework for Evidence-informed Public 
Health  
EIPH consists of certain key elements and their interactions – 1) Evidence; 
2) Public Health Policy; 3) Public Health Practice; 4) Heath Outcomes. In 
EIPH, both research evidence and other types of evidence are used to 
support development of public health policy and practice which in turn 
impacts on health outcomes of populations. Interactions between these 
elements are influenced by barriers and facilitators from the environments 
and their context in which the policies and practice are developed. Figure 1 
illustrates a conceptual framework for EIPH featuring its key elements and 
their interactions. 
Figure 1: Evidence-informed Public Health Framework
Gaps between elements of the EIPH framework exist due to the existence of 
barriers and/or absence of facilitators. These gaps include: 
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• "Evidence-to-policy" gaps exist when evidence is not adequately or 
appropriately considered and integrated in the development of policies.  
• "Evidence-to-practice" gaps exist when evidence is not adequately or 
appropriately considered and integrated in the development of 
interventions. 
• “Policy-to-outcomes” gaps exist when policies are not implemented 
adequately or appropriately. 
• “Practice-to-outcomes” gaps exist when practice is not implemented 
adequately or appropriately. 
The thesis presents the author’s published works undertaken to understand 
the ‘evidence-to-policy and practice gaps’ and demonstrate the use of 
approaches to bridging these gaps.  
Section 1.6: Aim and Objectives of the Thesis 
The thesis includes eight published works which report findings on 1) the use 
of evidence and barriers and facilitators of its use (Publications 1 and 2) and 
2) KT approaches facilitating co-creation of evidence in public health policy 
making and practice (Publications 3 to 8) – See Table 1. The objectives of 
this covering document are to highlight the significance of the published 
works as a contribution to original knowledge within the field and to provide a 
reflection on what has been learned through undertaking these works. The 
published works included are wide-ranging in terms of public health topics, 
contexts as well as the methodologies used. However, the fundamental 
theme common to all of them is EIPH.  
The eight papers were published in peer reviewed journals between 2009 
and 2017) and their full-texts are provided in Appendix 2. In sections 2 and 3, 
a summary of the published works is presented followed by their significance 
as a contribution to original knowledge.  Section 4 provides an overall 
reflection on the strengths and limitations of the published works in the 
context of existing literature and discusses their implications for future 
research. 
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Table 1: Published works mapped to research aims
Section Research Aim Reference of Published Work 
Se
ct
io
n 
2
Use of research and other types 
of evidence in developing public 
health policies 
Publication 1 
Hämäläinen, R.M., Aro, A.R., van de 
Goor, I., Lau, C.J., Jakobsen M.W., 
Chereches, R.M., Syed, A.M., REPOPA 
Consortium.and On behalf of the 
REPOPA Consortium. (2015) Exploring 
the use of research evidence in health-
enhancing physical activity 
policies. Health Research Policy and 
Systems. 13:43.    
Barriers and facilitators in the 
use of research and other types 
of evidence in developing public 
health policies 
Publication 2 
van de Goor I., Hämälainen R-M., Syed 
A.M., Lau, C.J., Sandu, P., Spitters, H., 
Eklund Karlsson, L., Dulf, D., Valente, A., 
Castellani, T., Aro A.R. (2017) 
Determinants of evidence use in public 
health policy making: Results from a 
study across six EU countries. Health 
Policy. 121(3):273-281 
Se
ct
io
n 
3
Knowledge translation 
approaches facilitating co-
creation of evidence to inform 
public health policy and practice 
The Delphi Technique 
Publication 3 
Syed, A.M., Hjarnoe, L., and Aro, A.R. 
(2009) The Delphi Technique In 
Developing International Health Policies: 
Experience From The SARSControl 
Project. The Internet Journal of Health. 
8:2. 
Publication 4 
Syed, A.M., Hjarnoe, L., Krumkamp, R., 
Reintjes, R., Aro. A.R. (2010) Developing 
policy options for SARS and SARS-like 
diseases – a Delphi study. Global Public 
Health. 16:1-13.  
Publication 5 
Syed, A.M., Camp, R., Mischorr-Boch, 
C., Houÿez, F., Aro, A.R. (2015) Policy 
recommendations for rare disease 
centres of expertise. Evaluation and 
Program Planning. 20 16;52:78-84 
Population Impact Measure 
Publication 6 
Syed, A.M., Talbot-Smith, A. and 
Gemmell, I. (2012) The use of 
epidemiological measures to estimate the 
effectiveness of planned interventions: 
Experiences from Herefordshire, UK. 
Journal of Epidemiology and Global 
Health. 2(3) 111-124.  
Coverage with evidence development 
Publication 7 
Syed, A.M., Mcfarlane, J., Chester, T., 
Powers, D., Sibly, F., Talbot-Smith, A. 
(2014) Clinical efficacy and cost-
effectiveness of Clostridium histolyticum 
collagenase injections in a subpopulation 
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Section Research Aim Reference of Published Work 
of Dupuytren's contracture patients. 
European Orthopaedics and 
Traumatology. 5(3): 311-316  
Publication 8 
McFarlane, J., Syed, A.M., Sibly, T.F. 
(2015) A single injection of collagenase 
clostridium histolyticum for the treatment 
of moderate Dupuytren's contracture: a 
2 year follow-up of 47 patients. Journal of 
Hand Surgery (European Volume). 
41(6):664-5. 
Section 1.7 Author’s Contribution to Published Works 
The author undertook the published works whilst working in a public health 
academic or a public health practitioner role. Publications 3 & 4 were 
undertaken whilst working in a research role at an academic institution. All 
publications were undertaken while working in various public health 
practitioner roles. Publications 1, 2, 3, 4 & 5, were undertake as part of larger 
European Commission (EC) funded research projects namely  
‘SARSControl’, ‘Research into POlicy to enhance Physical Activity 
(REPOPA)’ and Patients' Consensus on Preferred Policy Scenarii for Rare 
Disease (POLKA) projects. Publications 6, 7 and 8 were undertaken 
independently by the author and his colleagues. 
The five published works, wherein the author of the thesis is first author 
(Publications 3, 4, 5, 6 and 7); he was the principal investigator and 
undertook the data collection, analysis and drafting of the published work. 
For publications 1 and 2, undertaken as multi-country collaborative studies, 
the author of the thesis undertook the data collection and analysis for the 
studies in the capacity of a principal investigator within the UK country 
research team. These published works and Publication 8 were drafted by the 
first author of the individual studies and the author of the thesis contributed to 
drafting and revising them. 
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Section 2: Use of Evidence and its Barriers and 
Facilitators in developing Public Health Policies 
The use of best available evidence to support public health policy and 
practice has been strongly advocated. However, it is recognised that public 
health evidence must cover, not just the question of effectiveness of 
interventions; but also other pertinent information such as organisation, 
implementation and feasibility, which are less commonly covered by 
research evidence (Klein 2003). In this regard, public health evidence is 
neither perfect, complete nor unequivocal. Nevertheless, the large number of 
people affected by public health policy and practice highlights the need for 
robust decision making. Therefore it is essential to understand and map the 
use of evidence as well as identify barriers and facilitators for its use. This 
understanding will prove useful to develop approaches and interventions to 
promote and foster evidence use in line with EIPH. This section includes 
publication 1 which explores the use of evidence (i.e. establish an 
understanding of evidence-to-policy gaps) and publication 2 which explores 
the barriers and facilitators of evidence use in physical activity policy making 
(i.e. establish why evidence-to-policy gaps exist). 
Section 2.1: Use of Research and Other Types Evidence 
Publication 1:  Exploring the use of research evidence in health-
enhancing physical activity policies (Hämäläinen et al 2015)  
Background 
The health benefits of physical activity are supported by research evidence 
as well as the international public health community and its policies, including 
the World Health Organization (WHO 2010). The integration of physical 
activity as part of everyday life has been shown to be beneficial, especially 
for people with a sedentary lifestyle (Bucksch and Schlicht 2006, Proper et al 
2011, Lim et al 2012, Ekelund et al 2016). The urgency for global action is 
strengthened by new evidence in the Lancet’s 2016 Series about the effect 
of physical inactivity on dementia, the large health-care costs of inactivity, the 
additional health risks from excessive sitting, and, most importantly, the 
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observation that physical activity is not improving worldwide, despite an 
increased number of countries having a national physical activity policy or 
plan (Das and Horton 2016). The evidence of effective interventions is also 
increasing. Therefore action can be taken to reduce the impact of physical 
inactivity. However there still appears to be an overall lack of success in 
developing and implementing effective policies and interventions at the 
population level. This highlights a need to develop better approaches and 
interventions to bridge the evidence-to-policy and practice gaps. In order to 
accomplish this, it is essential to gain a better understanding of how research 
and other types of evidence are used in real-life physical activity policy 
development.  
In 2011, the EC funded the REPOPA project (www.repopa.eu). The overall 
aim of REPOPA was to integrate scientific research knowledge, expertise, 
and real world policy making processes to stimulate evidence-based physical 
activity policies. The aim, design, methods and preliminary baseline results 
of the overall REPOPA project are available in ‘Integrating research evidence 
and physical activity policy making-REPOPA project’ (Aro et al 2015). The 
aim of this published work was to explore the use of research evidence in 
health-enhancing physical activity (HEPA) policies, identify when research 
evidence was used, and indicate which other types of evidence were used in 
HEPA policy making.  
Methods 
In the REPOPA project, 21 HEPA policies implemented at local, regional and 
national levels in six European countries (Finland, Italy, Romania, UK, The 
Netherlands and Denmark) were selected for content analysis. Semi-
structured interviews were undertaken using a standard topic guide across 
all six participating countries. The interviews focused on perceptions and 
experiences of how research and other types of evidence were used in the 
policy making process and what factors facilitated or hindered their use in 
this process. The interviews were done by researchers from the respective 
countries in their native language. Each interview took about 1.5 hours, was 
tape-recorded and transcribed (tape-recording was done only when consent 
was given, otherwise notes were taken). 
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By purposeful sampling a total of 86 stakeholders which included policy 
makers, researchers, public sector officers and other influential stakeholders, 
who were directly involved in the policy making process of the selected 
policies and who could provide information about the use of research or 
other evidence in the policy making process were interviewed. All 
interviewees were contacted via email or phone by the research team in the 
country with information on the project and consent forms in the local 
language. The data collected were analysed by each country team using a 
common guideline for qualitative content analysis (analysis were carried out 
manually or using software packages for qualitative research such as NVivo, 
MaxQdata). Coding was done by two researchers independently from each 
other in the country teams. Each country produced a report presenting its 
findings which were integrated into a single project report in English.  
Results 
Based on the content analysis of policy documents and interviews, the types 
of evidence used were listed, the items from which were classified and 
categorised into research evidence and other types of evidence such as 
societal framework, media, everyday knowledge and intuition. 
Explicit citable use of research evidence was mostly found in the justification 
of HEPA policies and as a trigger to start development of a policy on the 
basis of a specific study or publication. The visions and goals of the policies 
were rarely validated by research evidence but by other types of evidence. It 
was found that implicit evidence, such as common knowledge, facts, and 
practices, were primarily used in policies. Policymakers obtained other types 
of evidence from experiences, such as earlier national or international good 
practices, projects or programmes, or information gathered from personal 
networks.
Where research evidence was used, it was identified in an ad hoc manner in 
the policy making phase and consisted of epidemiological research, 
population studies or statistics, and case studies. Peer-reviewed research 
articles and research based on surveys, as well as monitoring, evaluation, 
and implementation studies were rarely used. When the HEPA policies used 
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citable research evidence, it was not necessarily peer-reviewed scientific 
articles. Instead, various types of national and international reports and 
recommendations were used. In most cases, when paragraphs in the policy 
documents suggested being informed by scientific knowledge, explicit 
research evidence was seldom referenced. 
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Section 2.2: Barriers and Facilitators in the Use of Research and 
Other Types Evidence  
Publication 2: Determinants of evidence use in public health policy 
making: Results from a study across six EU countries (van de Goor et 
al 2017) 
Background 
Evidence-to-policy gaps related to evidence use are reported in Publication 1 
and other literature (Lomas 2000, Liverani et al 2013, McCaughey and 
Burning 2010, Orton et al 2011, Shine and Bartley 2011). This is despite 
strong economic and moral, and occasionally political, arguments for making 
better use of research evidence in policy making (Sebba 2011). Hence there 
is a need to understand why these gaps exist in order to develop approaches 
to bridge them.  
Preliminary results from the REPOPA project showed that supportive 
institutional resources, access to applicable context-relevant research 
evidence, media attention, good personal relationships and networks, joint 
language and collaboration between researchers and policy makers were 
found to facilitate the use of research evidence (Aro et al 2015). Barriers 
appeared to be related to a non-supportive institutional management, lack of 
easy access to best available evidence, limited contacts between 
administrative personnel, experts and researchers (Aro et al 2015). The aim 
of this published work was to further explore barriers and facilitators in the 
use of research and other evidence to developing HEPA policies. 
Methods 
Multidisciplinary teams from six European Union member states analysed 
the use of research evidence and other kinds of evidence in 21 HEPA 
policies and interviewed 86 key policymakers involved in the policies. 
Qualitative content analysis was conducted on both policy documents and 
interview data in each country (as described in methods section of 
Publication 1). 
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From the country reports, lists of the inductively identified facilitators and 
barriers for the use of research evidence were grouped and categorized 
using a concept map tool available online. The concept map tool helped to 
find associations and pull together similar items and separate differing items 
mentioned in interviews. By using the concept map tool the qualitative data 
from interviews formed a pattern of facilitators and barriers for the use of 
research evidence in HEPA policy making.  
Results 
A number of facilitators and barriers for the use of evidence in the process of 
policy development were identified when interviews were undertaken. 
Although facilitators and barriers were to some extent in itself 
complementary, the results show those factors that interviewees brought up 
as being mainly facilitating or mainly hindering the process of the use of 
evidence as they experienced it in their involvement in real world of policy 
making. Factors found to facilitate or hinder the use of evidence can be 
categorised into four main domains of which the first three are mainly about 
process and the last one mainly about collaboration between stakeholders: 
• Domain 1- Organizations, systems and infrastructure; 
• Domain 2- Media engagement and support; 
• Domain 3- Access and availability of relevant evidence; 
• Domain 4- Networking and collaboration between researchers and 
policy makers. 
In addition to the findings in these domains, factors that appeared specific 
within the country or policy context are described.  
Significance of published works 
Findings from Publication 1 suggest there is a lack of use of research 
evidence to support visions and goals of HEPA policies. Other types of 
evidence such as common knowledge, facts, and practices are primarily 
used. In EIPH, even though use of other types of evidence is essential, it is 
not the only type of evidence required. Other types of evidence are usually 
required to supplement research evidence, not to act as the primary and only 
source of evidence. These findings highlight a need to shift use of best 
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available research evidence as a primary source while other types are 
considered along with it as secondary sources in developing HEPA policies.  
This published work examined the use of research and other types of 
evidence by stage of policy making. It established that use of research 
evidence was mostly to justify initiating policy development and a specific 
study or publication was used as a trigger to initiate it. The contents of the 
actual policies were not backed up by research evidence but by other types 
of evidence. For the justification of the policies where research evidence was 
used, instead of using peer-reviewed scientific articles, the policymakers 
used various types of secondary publications, such as national and 
international reports and recommendations. The use of these secondary 
publications may be justified when they have been compiled through a 
transparent and rigorous process, but it was often unclear if their contents 
were evidence-informed and if they were critically appraised before their 
findings were quoted.  In defining the details of policies, such as setting of 
targets or actions for population groups, explicit research evidence was 
rarely used. These results help understand what type of evidence is used to 
inform policy development and at which stage, in effect mapping evidence 
types with their use in policy making stages. These findings whilst 
highlighting shortcomings in the use of research evidence also help 
understand how ideas spread through systems, how decisions are being 
made and the capacity required to use evidence. A systematic review by 
Orton et al (2011) reports types of research evidence preferred by public 
health decision makers and professionals. Studies on the actual use of 
research evidence were not reported potentially because they are lacking. 
Therefore findings from this published work are valuable to inform and 
improve EIPH by providing information on evidence-to-policy gaps related to 
evidence use. The information will help develop approaches to bridging 
these gaps in developing more effective HEPA policies. Such information is 
useful in developing interventions that can enhance the use of research 
evidence in real life policy making. An example of an approach where locally 
tailored interventions to increase levels of knowledge integration in evidence 
informed policy making demonstrated  is demonstrated by Bertram et al 
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(2016). The study used a ‘Stewardship’ approach to build needs and context 
based policy interventions with close collaboration between researchers and 
policy makers. The Stewardship approach guided the interventions which 
were designed on the basis of context- and needs assessments, and all 
activities were performed in close collaboration between researchers and 
policy makers. The ‘Knowledge to action’ framework was used to identify the 
various steps necessary to integrate evidence and knowledge in the policy 
process.  The level of research evidence and knowledge use was measured 
with pre-, post- and 12-month post-post measurements which showed an 
improvement in six policy development cases across three countries. 
Publication 2 reports on why evidence-to-policy gaps exist in real world 
HEPA policy making. Three findings from the study shed new light on the 
barriers and facilitators of evidence use in the policy making process.  First, 
the results showed that the attitude of media towards underpinning policy 
with evidence (as done in television debates, newspapers, social media) is of 
influence on evidence uptake in policy. Policy decision makers (e.g. 
politicians) may feel that the media’s attitude has a large impact on voters 
and therefore act accordingly. Reviews in the literature on barriers and 
facilitators in  evidence use in health policy mainly focus on factors 
influencing researchers, practitioners and policy officers as main 
stakeholders in the policy making process. Media was not found to play a 
substantial role among these (Hanney et al 2013, Oliver et al 2014, Wallace 
et al 2012, Lavis 2005, Orton et al 2011). The fact that the study found 
stakeholders mention media has impact on decision makers’ opinions on the 
use of evidence adds new insight to this knowledge. In addition, the rapid 
development of social media highlights the need to further examine emerging 
evidence in this important and evolving field. These findings indicate that the 
tactical or political model of evidence utilization in public health policy 
resembles reality more closely than the problem-solving or knowledge-driven 
model (Bowen et al 2005, Nutbeam 2003, Weiss 1979, Petticrew et al 2004).  
Second, personal characteristics of potential evidence users were highlighted 
as being important. Skills, attitudes and values of individual policy makers 
have an impact on the extent to which they will access and use best available 
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evidence. In a recent systematic review Oliver et al (2014) stated that 
improved skills are amongst the most frequently reported facilitators of 
evidence use. The study results also seem to be consistent with the 
‘interaction explanation’ according to which ‘knowledge utilisation depends on 
disorderly interactions between researchers and users’ and interactions 
across the interface between policy makers and researchers which are 
important for the transfer of evidence-to-policy (Landry et al 2003, Hanney et 
al 2013). Furthermore, results showed that although a solid research 
infrastructure is seen as a facilitating factor for research evidence use in 
policy making, it is not a sufficient condition for actual use of research 
evidence in the policy making process. Intensive and timely interaction 
between researchers and policy makers are reported as important factors for 
the use of research evidence in policy.  Actual use of research evidence 
requires both optimal policy relevance of available information and structural 
interaction between researchers and policy makers. Third and last, it was 
found that factors impacting evidence uptake in the policy making process 
interact in a complex way. Having ample access to research evidence is not 
a sufficient condition for policy decisions to be adequately evidence-informed. 
Decision makers’ e.g. politicians’ personal beliefs and perceptions as well as 
cultural circumstances and traditions in appreciating evidence or more 
system-oriented limitations will always interact with the mere availability or 
transferring of research evidence (Petticrew et al 2004, Best 2010). 
These results highlight the need for interventions to improve skills and 
change attitudes of policy makers as well as improving networks between 
them and researchers. The results also suggest the need to have effective 
communication plans and strategies in place and work with media in order to 
influence the use of evidence to inform decisions. 
Publication 1 and 2 were undertaken at EU level. This can be considered as 
their strength as findings provide an overview of evidence use in developing 
physical activity policies at EU level. This is based on the assumption that 
the six participating countries are similar and representative of other EU 
countries. However, individual EU countries vary in a number of ways. They 
have different infrastructures, processes, cultures, values etc. It must also be 
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noted that the findings are specific to the physical activity policies identified 
and included in the published work. Therefore caution must be exercised in 
interpreting the results as they cannot directly be generalised to other areas 
in public health, other countries and even other HEPA policies within 
countries from which the physical activity policies were selected for the 
study. Furthermore, the study used interviews as a data collection method, 
therefore the responses may have potentially been influenced by recall bias 
as some of the selected policies were developed some time before the 
interviews were conducted.  
The aim of Publication 2 was to identify barriers and facilitators of research 
and other types of evidence. The publication reported barriers and facilitators, 
however, it did not break the results down by type of evidence i.e. research 
evidence and other types of evidence. The majority of the results focussed on 
research evidence. This is a drawback of the published work. Approaches to 
facilitating the incorporation of other types of evidence with research 
evidence will be described and discussed in Section 3 of this thesis. 
Publication 1 and 2 were undertaken as part of work package 1 ‘Use of 
evidence in policy making’ of an EC – funded REPOPA project which 
included a total of seven work packages. The author of the thesis undertook 
the work as a principal investigator for work package 1 for UK as one of six 
countries involved. In addition to being published, its findings have been 
reported to the EC for consideration in its work to enhance EBPH policy 
development. Since becoming available in October 2015, the publication 1 
has been cited seven times and accessed 1523 times. Publication 2 was 
recently published and has not yet been cited.  
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Section 3: Knowledge Translation Approaches 
facilitating Co-creation of Evidence to inform Public 
Health Policy and Practice 
Publication 1 reported evidence-to-policy gaps in evidence use and 
Publication 2 reported why these gaps exist. These findings are useful in 
developing and employing approaches to bridging evidence-to-policy gaps 
and facilitate KT. 
Publication 2 also found, in public health, evidence of what works well may 
not be available or applicable in all settings, making it difficult to know 
precisely what policies or services to support for the best outcomes. 
Therefore, ensuring adoption of effective interventions is likely to depend on 
many factors such as what evidence is available and brought into play; what 
stakeholders want (managers, practitioners, the public, the government); 
what resources are available etc. To address this, evidence provided to 
policymakers needs to be in a form that is useful to them (Campbell et al 
2009, Woolf et al 2015). Policymakers require synthesised and localised data 
that demonstrates the need for a policy response, contrasts and prioritises 
policy options, demonstrates effectiveness, cost-effectiveness and impact of 
interventions, reflects the level of public support for a particular issue and 
personalises the problem as found in Publication 2. 
This section includes published works which utilised three approaches (the 
Delphi technique, Population Impact Measures and Coverage with Evidence 
Development) to facilitate knowledge translation to support EIDM. It 
illustrates how these approaches enable co-creation of evidence to inform 
public health policy or practice. The approaches presented in this section 
demonstrate how they can address findings related to evidence use in 
Publication 1 and some of the barriers and promote facilitators identified in 
Publication 2, such as relevance of research, lack of resources, lack of 
applicability of research etc. 
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Section 3.1: The Delphi Technique 
The Delphi technique, originally developed by the RAND Corporation (Adler 
and Zigilo 1996), helps in structuring a group communication process that is 
particularly useful when there is little knowledge or uncertainty surrounding a 
complex area being investigated (Dalkey and Helmer 1963, Linstone and 
Turoff 1975, McKenna 1994, Crisp et al 1997). This section includes three 
published works featuring the Delphi technique. Publication 4 and Publication 
5 demonstrate its application in co-creation of evidence to develop policy 
options in areas where there was a lack of knowledge and substantial 
uncertainty. Publication 3 evaluates the use of the Delphi technique based 
the experience of using it in Publication 4.
Publication 3: The Delphi technique in developing international health 
policies: Experience from the SARSControl Project (Syed et al 2009) 
Background 
The Delphi technique needs to be applied systematically and rigorously to 
produce reliable and valid results (Hardy et al 2004) and to avoid 
discrepancies (Keeney et al 2001). Based on literature, the five core criteria 
when using the Delphi technique are: a) panel composition: geographic and 
professional representativeness, size, heterogeneity (Hasson et al 2000, 
Jones and Hunter 1995); b) participant motivation: response rate, written 
consent, clarity of questions, reminders; c) problem exploration (Keeney et al 
2001); d) consensus definition e.g. as percentage of agreement /medians 
(Hardy et al 2004, Dajani et al 1979); and e) format of feedback e.g. 
individual responses, measures of tendency and spread of responses (Crisp 
et al 1997), different statistical description using median, mean or percentage 
(Jones et 1992) which can decrease unnecessary disagreement (McDonnell 
et al 1996). Other criteria include number of rounds, anonymity 
to encouraging open expression of opinions (Goodman 1987), and 
sufficient resources which include time and administrative services (Duffield 
1993). Appropriately addressing the issues while carrying out a Delphi 
process, determines efficient application of the method to obtain the desired 
result (Delphi outcome). The methodological challenges while carrying out 
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the SARSControl Delphi study (Publication 4) led to this evaluation study. 
The study assesses practical applicability of the Delphi technique in a real 
world setting and presents findings based on the criteria identified. 
Methods 
This study uses criteria identified from the literature to assess the process of 
using the Delphi technique in the SARSControl project. The evaluation was 
done using the qualitative description of the processes of SARSControl 
Delphi study and carrying out a critical analysis of different aspects of each 
criterion. 
Results 
The main weaknesses in the Delphi process employed in the SARSControl 
study were found to be the lack of experts in infectious diseases amongst the 
Delphi team, use of a 9-point Likert scale without clear verbal labels, lack of 
representatives from countries with SARS experience, discontinuity in the 
Delphi panel composition from the 1st to the 2nd round to the face-to-face 
meeting and delays in data gathering due to collaboration with another 
project. Despite the challenges, the Delphi study still proved to be a useful 
exercise that produced valuable policy options in an area where there was a 
lack of research evidence taking into account context. Future work can 
explore the applicability of this technique for other topics and settings of 
public health policy making, assess the relative importance and impact of 
adherence to commonly specified criteria for Delphi technique, and compare 
its effectiveness with other methods in promoting EBPH. 
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Publication 4: Developing policy options for SARS and SARS-like 
diseases – a Delphi study (Syed et al 2010) 
Background 
The 2002/2003 Severe Acute Respiratory Syndrome (SARS) epidemic shook 
the world, causing more fear and social disruption than any transmissible 
disease of our time. Like SARS, the H1N5 (bird flu) and H1N1 (swine flu) 
influenza outbreaks have also shown how emerging infectious disease 
pandemics can have social, economic and security implications on a global 
scale. 
The EC works to protect and promote the European population’s health, and 
thus considered it a priority to develop and implement policies on SARS and 
SARS-like diseases. To achieve its goal, the EC funded a three-year 
research project called ‘SARSControl’. The project’s main aim was to 
develop ‘Effective and acceptable strategies for the control of SARS and 
newly emerging infections in China and Europe’. This study was part of the 
‘Policy evaluation’ work package of the SARSControl project, the aim of 
which was to develop policy options using methodologies such as literature 
review, Hazard Analysis and Critical Control Points (Krumkamp et al 2009) 
and the Delphi technique to meet the project’s wider objectives. The final 
results of the SARSControl project were reported to the EC in 2008. 
The objective of the SARSControl Delphi study was to develop options for 
national and international emerging infectious diseases policies. These were 
lacking due to a lack of research evidence and uncertainty regarding SARS 
and SARS-like diseases as they were novel at the time. Therefore, there was 
an urgent need to gather the best available evidence to inform policy options 
to prevent and plan for future pandemics. The aim of the published work was 
to present results of the study, which co-created evidence to fill in the gaps 
and resolve inconsistencies concerning preparedness and response 
planning for SARS and SARS-like diseases.  
Methods 
The SARSControl Delphi study was carried out using the Delphi technique. It 
consisted of a pilot round, two written rounds and a face-to-face meeting. A 
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total of 60 experts were selected to represent the Delphi panel. Out of the 60 
experts selected (the majority of whom represented their countries on the 
Advisory Forum of the European Centre for Disease Control), 47 accepted 
the invitation; 38 experts from 22 countries (21 European countries and one 
South-East Asian country) replied in the first round and 28 of the 38 experts 
replied in the second round. Eleven experts were newly recruited for the 
face-to-face meeting, as none of the experts from the written round could 
participate in it. The Delphi questionnaire was prepared with a focus on 
addressing gaps and inconsistencies in pandemic preparedness and 
response planning identified by: reviewing scientific literature; reports on 
emerging infectious diseases; pandemic plans; guidelines and policies 
available in the ‘MEDLINE’ database, as well as through the ‘Google’ search 
engine using the search terms ‘emerging infectious diseases, SARS, 
pandemic influenza, health policies, pandemic plans, SARS guidelines, 
influenza guidelines’; using results from the SARSControl Project Hazard 
Analysis and Critical Control Points analysis (Krumkamp et al 2009); and by 
gathering input from the other SARSControl project work packages.
Results 
The Delphi technique helped develop a number of policy options that 
focussed on gaps and inconsistencies in pandemic preparedness and 
response planning whilst taking into account context at national and 
European levels. The Delphi panellists highlighted the necessity to test plans 
and stressed the importance of surveillance measures for the swift 
containment of communicable disease outbreaks and the inclusion of 
detailed triage plans in national pandemic plans. The experts also suggested 
a need to define criteria for testing pandemic preparedness plans at different 
regional levels. New policy alternatives were identified, such as the need for 
generic plans on pandemics and universal access to healthcare during an 
outbreak. The usefulness of some non-medical interventions, such as bans 
on travel, could not be established and were deemed to need further 
research. The findings were disseminated to help bridge gaps and rectify 
inconsistencies in pandemic planning and response strategies for SARS and 
SARS-like diseases, as well as added valuable knowledge towards the 
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development of national and international emerging infectious disease 
policies. The technique therefore helped co-create evidence by utilising 
knowledge and experiences of experts in the field. 
Significance of published works 
Approaches and methods for KT are increasingly being adopted to facilitate 
EIPH. However, the real life consideration in their application is  not always 
documented and discussed. Publication 3 evaluated the practical use of the 
Delphi technique in developing policy recommendations based on its 
application described in Publication 4. It identified a number of limitations in 
its application. This included the lack of experts in infectious diseases 
amongst the Delphi team, use of a 9-point Likert scale, lack of 
representatives from countries with SARS experience and discontinuity in the 
Delphi panel composition. In addition, Publication 3 provides advice and 
guidance on the key elements of the technique that need to be considered 
for anyone who may wish to utilise it to develop public health policy 
recommendations and highlighted some potential challenges. Publication 3 
attempts to do this in order to support future use of the Delphi technique. To 
the author’s knowledge, no published studies have explored and reported 
practical issues and know-how associated with using and evaluating the 
technique in real world health policy settings. More such evaluations are 
needed on both the Delphi technique and other similar tools that facilitate KT. 
They will be useful in developing guidance and training for public health 
professionals in their use. 
Publication 4 is an example of the Delphi technique and its use as an 
approach to support co-creation of evidence to inform development of public 
health policy options.  In Publication 4, it was employed as an innovative 
approach to develop public health policy recommendations in the field of 
SARS and SARS-like diseases. It was an area of policy development which 
was new and emerging at the time of the study with little previous research 
evidence and understanding of it  to inform policy options. This was one of 
the key reasons why the Delphi technique was chosen to undertake the 
studies: To enable structured communication and reach consensus on the 
basis of the limited research evidence and experience available to facilitate 
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co-creation of evidence to inform policy options.  The Delphi technique as a 
KT approach facilitates co-creation of evidence taking into account research 
and other types of evidence. Such approaches are not abundant or well 
described in published literature.  The results of Publication 4 add valuable 
knowledge towards the development of international policy options for SARS 
and SARS-like diseases. It also demonstrates the use of the technique and 
its value in areas where there is little previous research evidence available. 
Such scenarios are often encountered by policy makers in new areas  and 
new interventions within public health. The Delphi could potentially offer an 
EIPH based solution – supporting KT through co-creating evidence.  
Limitations and challenges of using the Delphi technique are reported in 
Publication 3. Both Publications 3 and 4 were funded by the EC and their 
results have been reported to the funder to inform future polices in the fields. 
The policy recommendations developed in in Publication 4 were reported to 
the EC who intended to bridge the gaps and rectifying inconsistencies in 
pandemic planning and response strategies to SARS and SARS-like 
diseases across the EU. The detailed technical report underpinning 
Publication 4 submitted to EC is available at 
https://survey.erasmusmc.nl/SARSControlproject/picture/upload/D_8_5%20
Delphi%20rounds.pdf. Publication 3 has been cited 16 times since it was 
published in 2009 and Publication 4 has been cited 15 times since it was 
published in 2010. 
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Publication 5: Policy recommendations for rare disease centres of 
expertise (Syed et al 2015) 
Background 
Rare diseases, defined as diseases that affect 1 (or fewer?) in 2000 
population, are a serious public health concern and are a priority in the 
European Union. In 2008, European member states and at European level 
there was a need for robust strategies, plans and specific policies on rare 
diseases (European Commission, 2008). Few European countries have 
specialised provision of health services for rare diseases. Despite a 
significant European Union population being affected by rare diseases 
healthcare systems in member states are not set up adequately to provide 
care for rare disease patients. In many European member states, rare 
disease patients are subject to marginalisation in classic healthcare systems 
designed for non-rare diseases (Kole & le Cam, 2010). As a result, patients 
with rare diseases do not experience equal access to timely, high quality 
health services they deserve (Kole & le Cam, 2010). The restructuring of 
healthcare systems to better reflect the values of equity and solidarity 
amongst rare disease patients, professionals, and policy makers across 
Europe needs to be accomplished. 
As part of the EC’s commitment to improving healthcare for rare disease 
patients, in 2008 a 3-year project called POLKA project was funded and 
supported by the EC. The main objective of the POLKA project was to 
facilitate the consultation of the European rare disease community, with the 
aim of building consensus on preferred public health policy scenarios for rare 
diseases, including the quality of care available at rare disease Centres of 
Expertise (CoEs), and if that level of quality was sufficient. 
In order to achieve the POLKA project’s objective of gathering expert advice 
and experience and building consensus on policies for CoEs on rare 
diseases, a study within POLKA called ‘The POLKA Delphi study’ was 
undertaken. There was a lack of existing research evidence to develop policy 
options in order improve patients’ experiences and meet expectations at 
CoEs as the concept was still new at the time.  The Delphi technique was 
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employed to co-create evidence for this purpose whilst considering   the 
specific experiences, setting and context.  This published work presents the 
results of the POLKA Delphi study and the policy recommendations 
developed from them aimed at better provision of healthcare for rare disease 
patients in Europe.  
Methods 
The POLKA Delphi study was initially planned to be carried out in rare 
disease CoEs from three countries ofDenmark, the UK and France. The 
countries were chosen as their healthcare systems were amongst the most 
developed ones set up to provide specialised care for patients with rare 
diseases in Europe. In majority of the member states, there is a lack of 
specialised services for patients with rare diseases through specialist 
healthcare centres/CoEs. This study presents results from Denmark and the 
UK as the French arm of the study encountered significant issues recruiting 
healthcare professionals, therefore was abandoned. The first step of the 
Delphi process was the selection of participants for the Delphi panel followed 
by administering a questionnaire survey (Round 1). The results of the 
questionnaire survey were fed back to the participants and used to facilitate 
discussions at face-to-face meetings (Round 2). The results of both rounds 
were collated and used to develop policy recommendations. The draft policy 
recommendations were sent to participants for validation and sign-off (Round 
3). 
A total of eight CoEs, one in Denmark and seven in the UK, participated in 
the study. A contact person at each of the eight CoEs was identified to recruit 
a total of 160 participants as the Delphi panel and coordinate the study – 8 
healthcare professionals and 12 patients (or patient representatives and 
carers) per CoE. Of these 134 participated in Round 1 and 65 participated in 
Round 2. 
Results 
The Delphi technique, by bringing together rare disease patients (or patient 
representatives and carers) and healthcare professionals, helped undertake 
a structured discussion on each policy area. The technique helped reach 
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consensus on the policy areas thereby supporting co-creation of evidence by 
utilising best available evidence and knowledge as well as experiences of 
individuals who had first-hand experience of the services that exist. The 
results suggested the need to make improvements within current CoE 
environments, access to CoEs and the need for coordination and 
cooperation of services within and outside CoEs. It was recommended that 
CoEs are not overly ‘medicalised’, while at the same time they should be 
established as research facilities. The importance of including patient 
representatives in CoE performance management was also highlighted. 
Raising awareness and provision of appropriate training amongst non-
specialist healthcare professionals was seen as a priority for early and 
correct diagnosis and ensuring high quality care. Similarly, provision of 
targeted information about patients’ illness and care was considered 
essential along with access to social assistance within CoEs. 
Policy recommendations were developed in areas previously recognised as 
having gaps. Their implementation is expected to strengthen and improve 
current care provision for rare disease patients.  
Significance of published work 
Publication 5 is another example of how the Delphi technique can be used as 
an approach to support co-creation of evidence to inform development of 
public health policy options.  Even though the development and 
establishment of CoEs and European Reference Networks was 
recommended and advocated, there was a lack of policy recommendations 
for CoEs and European Reference Networks. The area of policy 
development was new and emerging at the time of the study with little 
previous research evidence and understanding of it to inform policy options. 
This was one of the key reasons why the Delphi technique was chosen to 
undertake the studies. Its application in Publication 5 was based on the 
learning from Publications 3 and 4.  
Successful use of the Delphi technique in Publication 4 led to an invitation to 
undertake Publication 5. It was commissioned by the European Organisation 
for Rare Disease (EURORDIS) as they had recognised the potential of the 
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Delphi technique in developing policy recommendations for SARS and 
SARS-like disease in Publication 3 and 4. Implementation of policy 
recommendations developed using the Delphi study in areas previously 
recognised as having gaps is expected to strengthen and improve care 
provision for rare disease patients. In member states where national plans 
and strategies are being developed, EURORDIS is advocating the 
methodological approach used in Publication 5 as it proved to be a helpful 
tool in supporting disease CoEs policy development of rare disease CoEs in 
the UK and Denmark. As in Publication 4, the use of the Delphi technique in 
Publication 5 allowed a structured communication and informed development 
of policy options in areas with limited research evidence. It helped KT 
facilitating co-creation of evidence by addressing some of the barriers (such 
as lack of applicable research, exclusion of stakeholders, jointly working with 
researchers etc.) identified in Publication 2. The success of the Delphi 
technique and value shown by publications 3, 4 and 5 has also led to a fourth 
Delphi study in which it was used to develop evidence informed policy 
making indicators (Syed et al 2016).  
In Publication 5, the Delphi technique allowed bringing together a reasonably 
large number of participants for the study despite being geographically 
dispersed and required minimum resources. It must be noted that the 
majority of the study participants were from the UK which might be a 
limitation to the results of the study as UK recommendations might have 
been voiced more strongly compared to the Danish ones. This issue arises 
due to having separate face-to-face meetings in the two countries. It would 
have been ideal to have one face-to-face meeting for all participants rather 
than 7 (6 in the UK and 1 in Denmark) which would probably have resulted in 
a more constructive debate and equally voiced policy recommendations. 
However, this was not possible for three reasons, first because we were 
unable to coordinate patients to one venue given the severity of their 
conditions and ability to travel long distances, second because it was not 
possible to get availability of all HCPs on a given date and thirdly due to 
language. These are also the reasons why the proportion of participants in 
round 2 was lower (55% HCPs and 33% patients). In the UK, it was a 
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challenge to coordinate a face-to-face meeting in seven CoEs. Even though 
the results were from mainly form the UK and for specific rare disease CoEs, 
the results will be valuable to other EU countries and health planners. 
Publication 5 was funded by the EC and it has not yet been cited however it 
has been downloaded 471 times since it was published in 2015.  
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Section 3.2: Population Impact Measures 
Publication 6: The use of epidemiological measures to estimate the 
effectiveness of planned interventions: Experiences from 
Herefordshire, UK (Syed et al 2012) 
Background 
Coronary heart diseases, stroke and cancers are the major causes of 
mortality in the UK and are responsible for significant amounts of morbidity 
and healthcare costs. This published work examined the proportion of 
coronary heart diseases, stroke and cancer owing to specific risk factors in 
Herefordshire, UK. Therefore, this study was undertaken to co-create 
evidence by estimating the population impact of a number of interventions 
being implemented to reduce these risk factors, through the National Health 
Service (NHS) Health Check program and the Herefordshire Health 
Improvement Plan (HHIP). The NHS Health Check program is a screening 
programme mandated nationally, however the primary prevention 
interventions provided through it are decided locally. This study aimed to 
provide the evidence needed to help inform local decision makers prioritise 
investment of resources on primary prevention interventions based on the 
estimated health impacts on the population of Herefordshire by the NHS 
Health Check and HHIP.  
Methods 
The epidemiological measures – ‘Population Attributable Risk (PAR)’ and 
‘Population Impact Measures (PIM)’ – were used to assess the impact of 
interventions to reduce the burden of coronary heart disease, stroke and 
cancer. 
Results 
Application of PAR and PIM estimated that implementation of the NHS 
Health Check program will prevent 63 coronary heart disease events, 90 
myocardial infarction events and 125 stroke events, and one lung cancer 
over a period of 5 years. Reducing specific risk factors by 5% annually 
through the HHIP will prevent 65 coronary heart disease events, 25 
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myocardial infarction events, 140 stroke events, four lung cancer, one breast 
cancer and four colorectal cancer cases in Herefordshire if targets are met 
over a period of 5 years. 
The study, with help of PAR and PIM approaches, helped co-create evidence 
to inform public health practice. The epidemiological measures helped 
quantify the impact of public health interventions outlined in the NHS Health 
Checks program and the HHIP on health events for coronary heart disease, 
strokes and cancers if implemented locally. This was necessary as there was 
a lack of evidence-based impact information, in particular, intervention 
effectiveness expressed as adverse health events averted, to enable and 
influence decision makers to make informed decisions on prioritising and 
investing resources into public health interventions to prevent these 
conditions. 
Significance of published work 
Mobilizing research evidence for decision-making is challenging for health 
system decision-makers (Ellen et al 2014). Publication 2 identified the lack of 
applicable research as a barrier in the use of evidence to support public 
health policy and practice. This results in society paying a high opportunity 
cost when interventions that yield the highest health return on an investment 
are not implemented (Fielding 2001).  Furthermore, resource investments in 
primary prevention interventions are often diverted because decision makers 
are unable to justify investing in them because they do not have evidence of 
their impacts as outcomes are seen after long periods of time. Their 
preference tends to favour investment in interventions to treat acute 
conditions as they demonstrate outcomes in the short term. As highlighted in 
Publication 2, this may be because decision makers would like to have 
appositive impact on the public via the media. Such impacts cannot easily be 
demonstrated for primary prevention interventions. An example of such 
investment in England is that of the Cancer Drugs Fund from 2010 to 2016. 
£1.27 billion of tax payers money was spent based on an election promise 
that it would give patients increased survival1. Another potential reason for 
1 http://www.bbc.co.uk/news/health-39711137
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not investing in primary prevention interventions is the lack of evidence of 
benefit as well as ability to quantify outcomes of primary prevention 
interventions at local level.  
Publication 6 was undertaken to overcome the highlighted barriers in the 
County of Herefordshire, UK. It is an example wherein epidemiological 
measures were used in providing evidence-informed public health 
information in local policy making to aid decision makers when prioritising 
investments and optimal use of resources. Publication 6 demonstrates an 
innovative application of PARs and PIMs to support KT facilitating co-
creation of evidence. The epidemiological measures used in the study 
proved to be useful tools and their use can be recommended to support 
prioritisation of primary prevention interventions in similar settings. The 
findings of Publication 6 helped utilise research evidence to demonstrate the 
potential population impacts that can be achieved by implementation of 
primary prevention measures, through the NHS Health Check program and 
HHIP locally in Herefordshire.  
Publication 6 highlighted that physical inactivity and obesity levels are the 
most significant causes of coronary heart disease and stroke events in 
Herefordshire. Their impact is greater than the combined effect of 
hypercholesterolemia and hypertension together, both of which are well 
recognized and treated risk factors. These findings have helped assist local 
decision makers when prioritising investments and ensuring optimal use of 
resources.  
It must also be noted that approaches used in Publication 6 also have 
limitations (such as availability and quality of local data, varying disease 
definitions etc.) which must be considered. The findings from Publication 6 
are inherently dependent on the quality of the source data as PARs and the 
PIMs methodology use published risk estimates (i.e., baseline risk of 
disease, risk ratio (RR) and the relative risk ratio (RRR) of the intervention of 
interest), which carry a margin of error. Furthermore, published data sources 
use different definitions of disease status and outcome and present their 
results over different time-frames, age groups, and may or may not split them 
by gender. To limit the risks associated with using isolated published 
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sources, the parameters used in this study were derived from systematic 
reviews or meta-analyses; whose study question matched closest to this 
study’s target population and planned interventions. However, this was not 
always possible owing to limitations in the availability of data in the literature, 
and being  itself a time-consuming and challenging process, which could be 
seen as a limitation to the use of these epidemiological measures. 
It is well known that decision makers hesitate to invest resources in public 
health as they are unsure of the impact compared to investing in acute 
healthcare interventions (Orton et al 2011a). The application of the PIMs and 
PARs was an innovative approach to mitigate this and to support and 
advocate investment at local level. Through the combined use of published 
literature and local data, it provided information on the potential benefits of 
public health interventions in the form of potential adverse health events 
prevented. This was particularly helpful as it gave local decision makers a 
‘currency’ to demonstrate potential local impact. The approach was however 
not without drawbacks. Many assumptions needed to be made, and 
extensive background data collection was required in order to produce 
estimated for PIMs and PARs. Had a population cost impact analysis tool 
been used as part of the study to add an additional dimension in terms of 
cost impact for decision makers, it would have added further value. However, 
this was not possible due to the lack of resources and skills within the 
research team. Nevertheless, the work has proven useful within these 
limitations, and it has been used and replicated by other organisations for 
their local populations. It highlights the need for improved local health 
information systems and enhanced training of public health professionals 
that facilitates KT. 
This study is the first of its kind to use both epidemiological measures (PARs 
and PIMs) to model outcomes of two complex public health programs. It 
included six interventions and three disease areas. This is advantageous as 
it represents real life public health programs; however it is difficult to estimate 
the interactions between modifications of different risk factors. Consequently, 
it may not reflect precisely the impact of combined interventions on the 
outcomes, for example weight management and physical activity 
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interventions will both have an effect on the need for antihypertensive 
treatment in some individuals. However, an advantage of this study is that 
wherever possible, compliance to interventions was considered, using values 
derived from the literature. Therefore, the outcomes were based on the 
assumption that health behaviour factors of the local population were similar 
to the population included in the study. 
Cost-effectiveness of the interventions was not considered in this study as it 
was not its primary aim. The NHS Health Check program is a national ‘must-
do’, and the study’s aim was to achieve organization support locally to aid 
implementation. However, an advantage of using the PIMs methodology is 
that a cost dimension can be introduced to it if an economic assessment of 
interventions is required by health planners. One possibility is to adopt a 
methodology called ‘population cost-impact analysis’ described by Heller et 
al. (2006). It helps add a new dimension to economic analysis, the ability to 
identify costs and benefits of potential interventions to a defined population, 
which may be of considerable use for policy makers working at the local 
level. 
Following the publication of the study, a number of other healthcare 
organisations responsible for public health funding in the UK have 
approached the authors for support and advice in undertaking a similar 
studies for them. The published work has been cited 5 times since it was 
published in 2012. 
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Section 3.3: Coverage with Evidence Development 
One of the barriers in the use of evidence identified in Publication 2 was the 
lack of relevant research evidence to inform public health policy and practice. 
In order to address this barrier, a KT approach is ‘Coverage with evidence 
development’ (CED). The CED approach attempts to ensure that access to 
new interventions is not prevented due to uncertainties associated with 
available research evidence but is managed in a coordinated way, while also 
generating additional evidence to inform policy and practice (Lexchin 2011). 
This section includes two published works on CED. Publication 6 and 7 
demonstrate its application in co-creating evidence to inform public health 
practice for an intervention with uncertainties associated with available 
evidence. Publication 7 reports findings at 12-month follow-up and 
Publication 8 reports findings at a longer follow-up of 24 -months. The 
summary and significance of both published works is presented together 
after publication 8. 
Publication 7: Clinical efficacy and cost-effectiveness of Clostridium 
histolyticum collagenase injections in a subpopulation of Dupuytren's 
contracture patients (Syed et al 2014) 
Background 
There is increasing interest in the use of Clostridium histolyticum collagenase 
(CHC) injections to treat Dupuytren's contractures. However, the reported 
efficacy varies between studies and it remains unclear which patients would 
benefit most from CHC injections. In addition, there is a lack of national 
guidelines on its use. Therefore, there has been considerable debate in 
funding CHC injections by the UK's National Health Service. This study uses 
the ‘coverage with evidence development’ concept to facilitate co-creation of 
evidence to inform local policy and practice on CHC injections to treat 
Dupuytren’s contracture. 
Methods 
A literature review was undertaken to establish the best available evidence 
on CHC injections. This was analysed and translated to develop clinical 
criteria wherein the intervention is likely to be most clinically and cost-
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effective. A pilot study using the criteria was designed, and 56 patients were 
included. Efficacy assessments were undertaken by measuring contracture 
angle of the effected metacarpophalangeal (MCP) joint using goniometry and 
the Unité Rhumatologique des Affections de la Main (URAM) scale with 
follow-ups at 1, 3, 6 and 12 months. 
Results 
Significant improvements were seen in contracture angles as well as URAM 
scores when mean baseline and post-intervention outcomes were compared 
at 1, 3 and 6 month follow-ups. The mean contracture angle at 1 month 
follow-up (n = 56) was −0.9° (±8.1) and at 6 months follow-up (n = 29) was 
0.4° (±2.4), compared to 43.2° (±9.0) and 41.8 (±9.7) at baseline, 
respectively, showing mean improvements of over 40°. Mean URAM scores 
improved from 16.3 (±9.6) at baseline to 1.9 (±3.3) at 1 month of follow-up 
(n = 56) and from 16.9 (±9.8) to 0.8 (±2.8) at 6 months of follow-up (n = 39), 
showing improvements of over 13 points. Most treatment-related adverse 
events were mild or moderate in intensity and resolved without intervention 
within a median of 10 days. An overall cost savings of £104,732 was made in 
the cohort of 56 patients compared with alternative treatments available. This 
study, with the help of the CED approach, helped co-create evidence to 
inform local public health policy and practice for the interventions where 
there were uncertainties previously.  
 45 
Publication 8: A single injection of collagenase clostridium 
histolyticum for the treatment of moderate Dupuytren's contracture: a 
2 year follow-up of 47 patients (McFarlane et al 2015) 
Background 
This published work is a further follow-up of Publication 7 - Syed et al (2014). 
49 consecutive patients were treated with a single injection of collagenase 
for MCPJ contractures due to Dupuytren’s disease were followed up for a 
period of 2 years and their clinical and cost-saving outcomes are reported. 
Methods 
Ranges of motion and contracture were measured with a handheld 
goniometer, pre-operatively and at the final follow-up to assess clinical 
efficacy. URAM scores were measured to assess subjective change. Costs 
of the injection of collagenase, partial fasciectomy, and percutaneous needle 
fasciotomy treatment were computed from the cost to the hospital of the 
treatment, outpatient appointments, and hand therapy sessions.  
Results  
Significant improvements were seen in contracture angle and URAM scores. 
The mean contracture angle improved from 42° pre-injection, to 11° at 
24 months. The mean URAM scores improved from 17 prior to treatment, to 
3 at 24 months. A saving of £1870 per patient was made for CHC injections 
compared with partial surgical fasciectomy. Relative to percutaneous needle 
fasciotomy, CHC injection treatment is £604 more expensive per patient. 
Recurrence, defined as a contracture angle of greater than 20°, occurred in 
25% of patients (range 22° to 36°); of those, only one patient (2% of the 
whole group) with a contracture angle of 35° required further treatment with a 
fasciectomy. Overall, 76% of the patients who received collagenase reported 
at least one treatment-related adverse effect. Most side-effects were mild 
and resolved without intervention within a median of 10 days. The common 
side effects were skin tears, bruising, and axillary swelling. No severe 
adverse effects were reported. 
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On the basis of the results at 2 years following intervention, a single injection 
of CHC in selected patients with moderate Dupuytren’s contracture affecting 
only one MCPJ can be recommended as both a clinical and cost-effective 
treatment regime.
This study, with the application of the CED approach, helped co-create 
evidence to inform local public health policy and practice for the CHC 
injections when there were uncertainties and added further confidence in 
findings reported in Publication 7 due to its longer follow-up.
Significance of published works 
The quality of existing evidence is often insufficient to address the needs of 
decision makers as identified in Publication 2. There is often residual 
uncertainty following systematic reviews, mainly due to inadequate evidence 
of efficacy. Evidence may be lacking or may not be generalizable. For these 
reasons, contextualized “real-world” effectiveness data may be useful in 
aiding the decision-making process (Ung et al 2009) The unwillingness to 
make decisions in the presence of uncertainty may lead to passive diffusion 
and intuitive decision making with or without public pressure (Levin et al 
2011). This may affect health system sustainability. There is increasing 
interest in post-market evaluation to address residual uncertainty regarding 
effectiveness and cost-effectiveness.  
CED is another KT approach that was adapted to support decision making in 
the use of CHC injections to treat Dupuytren’s contractures. It was 
particularly useful in an area where there is uncertainly on clinical benefit of 
the intervention from existing clinical trials. Even though Publication 7 and 8 
do not provide conclusive evidence to support decision making, they set out 
a robust hypothesis which needs to be tested further in more rigorously 
designed studies. The study could be used to support potential future funding 
requests to undertake more robust clinical studies. It would have been more 
beneficial had Publication 7 and 8 adopted a randomised study design with a 
comparator group and larger sample size to increase reliability of the results. 
However, given the studies were undertaken in a non-research health 
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organisation with an imperative to make decisions quickly, it was not 
considered possible. 
CED is a mechanism for going beyond a binary yes/no decision about 
coverage for new technologies or drugs by offering coverage in the context 
of prospective studies (Chalkidou et al 2008). It provides an alternative in 
situations where an intervention does not appear to meet the standard 
criteria for reimbursement, predominantly because of uncertainty surrounding 
the existing evidence base and when additional data collection could reduce 
this uncertainty (Claxton et al 2012). CED is an approach which allows 
conditional funding of a promising health intervention while more conclusive 
evidence is gathered to address uncertainty regarding its clinical or cost 
effectiveness (Tureman et al 2010). The approach helps make important 
contributions by co-creating evidence to inform public health policy and 
practice.  
CHC is a new health technology to treat Dupuytren's contractures. There has 
been a growing interest to use it. However, its efficacy has been reported to 
vary in previously published studies. There has been considerable debate in 
funding CHC injections by the UK's National Health Service. The reason for 
this has been the weaknesses in the study designs, such as the efficacy 
measurements employed and the use of multiple injections and also the lack 
of analysis and reporting of data by disease severity, treatment cycle and 
joint type in some studies. All these factors combined together made it 
difficult to establish clinical efficacy and cost-effectiveness with fewer or 
single injections.  Publication 7 and 8 are an example which demonstrates its 
use in establishing the benefit of CHC injections to inform development of 
local health policy and inform clinical practise in Herefordshire, UK. Given the 
uncertainties around the CHC injection, rather than deny coverage for it or 
grant unlimited coverage, the published works by using CED, attempts to 
ensure that patients' access is not prevented but is managed in a 
coordinated way, while also generating additional evidence to reduce any 
uncertainty about value.
Global experience of CED has been slow to develop despite their potential 
contribution to decision making. In the UK, similar schemes have been set up 
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in specialised commissioning within the NHS called commissioning through 
evaluation (CtE) to support decision making of interventions usually for rare 
diseases. Due to the small number of patients, it may not always be feasible 
to undertake large scale randomised control trials. The CtE scheme is aimed 
to overcome this issue. The CHC study was undertaken prior to the 
development and setting up of the CtE scheme. The author’s experience in 
undertaking the study had a role supporting the NHS England national 
Specialised Services team in developing and setting up of the CtE 
programme in the NHS. He is currently involved in supporting evaluation of 
CtE studies. 
It must also be noted that there are limitations to the use of a CED approach. 
A decision to use it as an approach to manage uncertainties must be made 
carefully. It should not be recommended for every new intervention. Such a 
move could potentially encourage the healthcare industry to move away from 
undertaking rigorous research in the form of randomised control trials. 
Furthermore, CED takes away the risk of introducing interventions of low 
benefit and/or safety from the healthcare industry. Therefore risk sharing 
approaches, where payments for the treatment are linked to outcomes, may 
be more advantageous than CED particularly when it relates to high cost or 
high budget impact interventions. 
A limitation of Publications 7 and 8 is the relatively small sample sizes with 
clinical efficacy results reported at 12 and 24 months of follow-up 
respectively. The studies lacked a comparator group and the indirect 
comparisons made with previous published studies should be interpreted 
with caution. It is also known that late complications from CHC use can and 
have occurred outside the follow-up period of the initial phase III trials. 
Therefore, longer-term follow-up of patients is thus essential and further 
investigation and characterization of the late effects of CHC use is 
necessary. Furthermore, the cost analysis, which was based on the local 
information and setting, did not include longer term impacts on quality of life 
of patients and may not be generalizable. Further well-designed studies are 
needed to endorse findings, and surgical fasciectomy remains the gold 
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standard for the treatment of patients with severe Dupuytren's contractures 
involving multiple joints. 
Publication 7 has been cited 3 times since it was published in 2014. 
Publication 8 has not been cited yet since it was published in 2015. 
Publication 7 has been included as part of the evidence to develop a NICE 
technology appraisal guideline which is due to be published in the coming 
months. 
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Section 4: Discussion and Implications for Future 
Research 
Section 4.1: Discussion 
EIPH is a fundamental concept for public health policy and practice. Despite 
the many accomplishments of public health, a greater attention to evidence-
based approaches is warranted (Brownson et al 2009). The published works 
included in this thesis present important findings on the use of evidence and 
barriers and facilitators of its use thereby adding valuable knowledge to the 
field. It reports research evidence is rarely used in public health policy 
making. Other types of evidence are given more consideration and are 
primarily used. A number of barriers and facilitators in four domains 
(organizations, systems and infrastructure; media engagement and support; 
access and availability of relevant evidence; and networking and 
collaboration between researchers and policy makers) were also identified. 
Together, these findings provide an understanding of evidence-to-policy and 
practice gaps which is necessary to bridge them.  The application of three 
approaches - the Delphi technique, Population Impact Measure and 
Coverage with Evidence Development methodologies – to positively address 
evidence-policy and practice gaps and enable KT facilitating co-creation of 
evidence to inform public health policy and practice in the areas of SARS 
and SARS-like diseases, rare diseases, cardiovascular diseases, strokes, 
cancers and Dupuytren’s disease is presented.   
Despite being well acknowledged that the use of research evidence in 
developing public health policy and practice improves outcomes, findings 
from the thesis show that in real world settings, decisions are mainly based 
on other types of evidence. There are a limited number of studies that have 
quantified what and how different types of evidence are used (Orton et al 
2011, Amara et al 2004, Ouimet et al 2010, Oxman et al 2009a). A 
systematic review by Orton et al (2011) with an objective to synthesise 
evidence on what types of research evidence are used by public health 
decision makers reported two studies. These studies however focussed on 
types of research evidence preferred by public health decision makers. 
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Studies on the actual use of evidence were not included. This is potentially 
due to the fact that such studies were lacking at the time the review was 
undertaken.  More recently, Zardo and Collie (2014) using a policy content 
analysis found that research evidence was the least used type of evidence in 
128 injury rehabilitation compensation policies from the Victorian state 
government transport accident compensation authority in Australia. In 
another study that sought to measure the use of research, the frequency of 
use and the main purpose for use in comparison to other information types 
within two public health government agencies through a survey, it was found 
that internal data and reports were most frequently used sources of evidence 
while research evidence was the least frequently used source (Zardo and 
Collie 2015). This study also found that when used, research evidence was 
used for instrumental purposes more often than for symbolic purposes, which 
is contrary to findings of previous research. In general, the findings from the 
limited published literature are in line with those found by the published work 
in thesis. They provide further validation on what and how different types of 
evidence are used in physical activity policy making and could potentially be 
generalised to other health promotion areas given the similarities in policy 
development across them in terms of stakeholders, policy makers, 
organisations process etc. The limited studies available also support the 
need for KT approaches facilitating co-creation of evidence.  
A thematic analysis of a recent systematic review of barriers and facilitators 
of research evidence shows similarities with those found in published work 
included in the thesis (Orton et al 2011, Oliver at al 2014). The published 
work confirms that most of what is already known from recent literature on 
key hindrances in uptake of evidence in policy making from other countries 
(including low and middle income countries) also holds true at a European 
level. In addition, it identified some barriers and facilitators (such as political 
relevance of the policy area) that were specific to the country context and 
influential in decisions. This highlights heterogeneity in the public health 
policy making landscape between countries (i.e. heterogeneity in definitions, 
processes, structures, stakeholders etc.) Such comparative findings have 
previously not been reported in the published literature.  
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Publication 2 found multiple barriers accounted for the evidence-to-policy 
and practice gaps, and many were intrinsic to the stakeholders and their 
environment or context. For example, organisational constraints, such as 
lack of time or an inability to access resources, were found to be common 
barriers to KT. Six published works (Publications 3, 4, 5, 6, 7 and 8) 
demonstrate the innovative application of three KT approaches (Delphi 
technique, PIMs and PARs and CED) facilitating co-creation of evidence 
(research evidence together with other types of evidence) in real world 
settings with an aim to address the barriers and bridge the evidence-to-policy 
and practice gaps. All three approaches had previously been reported in 
literature and applied in different public health areas and settings. This 
demonstrates their ease of access and their ability to be tailored to specific 
requirements. In the published works, the three KT approaches were used as 
single KT approaches in as they were simple to use and did not require as 
much resources as multifaceted approaches. The impact of their application 
resulted in changing both knowledge and practice.  These experiences of 
using the three KT approaches are in line with those reported by in a 
systematic review by LaRocca et al (2012). They suggested that KT 
approaches that are accessible and can be tailored to the needs and 
preferences of the users are more successful; they also reported that simple 
or single KT approaches were shown in some circumstances to be as 
effective as complex, multifaceted ones when changing practice including 
tailored and targeted messaging. The difference between the KT strategies 
considered in the systematic review (LaRocca et al 2012) and those 
considered in the thesis is that the former facilitated use of research 
evidence only while the latter facilitated co-creation of evidence. The findings 
from the thesis demonstrate that the experiences and  outcomes of KT 
facilitating research use only and KT approaches facilitating co-creation are 
similar. 
KT approaches can be (a) driven by researchers, (b) driven by decision-
makers or (c) designed to develop partnerships between researchers and 
organisations to support the use of research evidence in public health 
decision making (Armstrong et al 2011). The KT approaches used in this 
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thesis were driven by researchers - the authors of the published works acted 
as a knowledge broker to link the research with decision makers. Depending 
on who drives the KT approach, there are practical implications. Resources 
in various forms such as access to technical information, expertise, 
collaboration with stakeholders, time etc. will be required. If the necessary 
resources are not available, these may pose as barriers in their use. It must 
be noted that no approach will be able to address all the barriers associated 
with their use due to the many variables associated with their use and the 
complexity of public health policy making environments.  However, aiming to 
reduce barriers in the use of evidence in the wider context will make their 
application easier.  
Section 4.2: Strengths and Limitations 
The thesis includes published works and their findings on a wide range of 
public health areas and settings at local, national and international levels. 
Therefore, it makes the findings relevant to a wide audience. The published 
works also employed a variety of existing and widely reported 
methodological approaches which increases the reliability and validity of 
findings. However, their use as KT approaches facilitation co-creation of 
evidence and also of other approaches has previously not explored. All of 
these factors add value to findings of the thesis. 
While it is advantageous that the published works and their findings were 
based a wide range of public health areas, settings and administrative levels, 
it is also a limitation as it was not possible to explore themes that were 
identified in greater detail. Another limitation of the thesis is that the KT 
approaches employed in it were researcher initiated. Therefore their use 
many be limited where individuals with such expertise are not available. 
Furthermore the KT approaches included in the thesis focussed on 
disseminating evidence only. It did not include approaches where in 
evidence was actively sought or those that build partnerships between 
researchers and decision makers. 
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Section 4.3: Implications for Future Research 
Advances in technology have led to increased adoption of tools and methods 
aimed at integrating diverse evidence sources to inform decision-making 
(Hovmand et al 2012, Atkinson et al 2015). While there are many KT 
approaches and techniques available, the research on evaluation of their use 
is still in its infancy (Freebairn et al 2016). Rigorous assessment of the value 
and utility of these methods and tools is required prior to them being more 
generally adopted to support for evidence-based public health decision 
making (Freebairn et al 2016). This is particularly necessary given that KT 
approaches have not demonstrated positive changes (Kiefer et al 2005) and 
their potential failure may be due to the use of a narrow definition of evidence 
as research evidence only in them (Kothari et al 2012). More studies need to 
be undertaken using a boarder definition of evidence which includes other 
types of evidence and facilitates co-creation and their evaluations reported. 
Future research should aim to address this and also explore how, when and 
why different facilitators and barriers come into play during the policymaking 
process as there is a lack of studies reporting on these factors (Oliver at al 
2014).  
In general, KT approaches can be categorised as having push, pull and 
exchange foci (Lavis 2006). Push approaches generally focus on 
dissemination (for e.g. development and distribution of publications, reports, 
systematic reviews, evidence summaries etc.). Approaches may support the 
uptake or reach of these products (Lavis 2006; Nutley 2007). Pull 
approaches may involve a number of mechanisms including social influence, 
facilitation and incentives and reinforcements. These may involve training 
staff in the application of research to decision making, employment of 
facilitators (also known as knowledge brokers) within decision-making 
contexts, rapid-response units, and development of project templates that 
instruct staff to provide rationale for their activities (Lavis 2006, Nutley 2007). 
Exchange approaches focus on improving the interactions between the 
researchers and decision-makers. This may include the establishment of 
networks or formal partnerships to support evidence informed decision 
making, prioritisation efforts (where decision makers identify their priorities, 
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turn the questions into researchable questions and promote research into 
these questions), and the use of knowledge brokers where their role is to 
facilitate partnerships. Further work is needed to explore pull and exchange 
approaches as the KT approaches included in this thesis were push 
approaches. 
Characteristics of decision makers were identified as factors that influence 
use of evidence in the thesis. Based on the experience of using KT 
approaches, it is considered that interventions to strengthen attitudes and 
competencies toward KT activities may trigger intention to systematically 
incorporate the best available evidence into policy making and practice. For 
policy-makers, it is thought that factors at the individual level that significantly 
predict research use in certain public health decision-making contexts 
include research skills and intention to use research findings in the near 
future (i.e., the next 12 months) (Zardo and Collie 2014). Further 
understanding of the relevant theoretical and empirical literature; mapping 
publications for key themes and research gaps of KT competencies, and 
interventions for enhancing KT competencies, is needed. Mallidou et al 
(2017) have planned a scoping review on KT competencies. Findings from it 
may be useful in the development of comprehensive training programs and 
implementation of research findings and undertake further research where 
there are gaps.   
Section 4.4: Conclusion 
A fundamental concept of EIPH is to take into account realities of a specific 
real-world environment when translating research evidence into policy and 
practice. This thesis presents an understanding of how evidence is used, 
barriers and facilitators of its use and potential KT approaches facilitating co-
creation of evidence to foster EIPH. 
It is essential that approaches supporting the use of research and other 
types of evidence in public health continue to be developed and evaluated. 
Usefulness and effectiveness of different KT approaches to facilitate 
evidence use and reduce its barriers must be documented in the literature so 
that they can be adopted or modified accordingly. Effective strategies and 
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interventions along with information of the settings in which they are 
delivered can then be utilised by public health professionals and policy 
makers who wish to promote EIDM. 
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